Interfering with Cell-Survival Signalling as a Treatment Strategy for Prostate Cancer (PDF)
A mounting body of evidence implicates dysregulation of cell-survival signalling pathways in the pathogenesis of hormonerefractory prostate cancer (HRPC), and with the activation of survival mechanisms that counteract chemotherapeutic treatment options.

BJUI Mini Reviews 2006 June

Chemotherapy for High-Risk Localized Prostate Cancer (PDF)
Prostate cancer is the most commonly diagnosed cancer in men in the USA except for skin cancer, and is the second leading cause of cancer mortality in men.

BJUI Mini Reviews 2006 April

Leuprolide Acetate Is A Familiar Drug That May Modify Sex-Offender Behaviour: The Urologist's Role (PDF)
The early history of treatment of paedophilia has paralleled the treatment of prostate cancer.

BJUI Mini Reviews 2006 April

Current Role of Prostate-Specific Antigen Kinetics in Managing Patients with Prostate Cancer (PDF)
PSA is the most widely used tumour marker in clinical practice, but the value of PSA in identifying patients at increased risk of prostate cancer is controversial.

BJUI Mini Reviews 2006 March

Radical Prostatectomy with Positive Surgical Margins: How Are Patients Managed? (PDF)
The last decade has seen a trend towards organ-confined prostate cancer, primarily due to the widespread use of PSA testing [1].

BJUI Mini Reviews 2006 March

Recent Improvements In Transurethral High-Frequency Electrosurgery Of The Prostate (PDF)
For many years TURP has been the standard method for treating LUTS resulting from benign prostatic enlargement (BPE), characteristically giving immediate success on removing the obstruction, and long-lasting improvement of symptoms and voiding varables [1].

BJUI Mini Reviews 2006 February

Hope Springs Eternal: Cavernosal Nerve Regeneration (PDF)
Prostate cancer is the most common internal malignancy affecting men in the Western world. Retropubic radical prostatectomy (RP) is a widely accepted form of curative treatment for localized prostate cancer, and is performed in a substantial proportion of men with the disease.

BJUI Mini Reviews 2006 January

Side-Effects Of Treatments For Locally Advanced Prostate Cancer (PDF)
Locally advanced prostate cancer (LAPC) is a clinical diagnosis whereby the tumour has extended beyond the prostatic capsule with no evidence of nodal or distant metastatic spread [1].

BJUI Mini Reviews 2006 January

Zoledronic Acid Is Effective In Preventing And Delaying Skeletal Events In Patients With Bone Metastases Secondary To Genitourinary Cancers (PDF)
Prostate cancer is the most commonly diagnosed cancer among men in the USA and the second most common cause of cancer-related deaths in men [1].

BJUI Mini Reviews 2005 November

The Need To Reduce Patient Discomfort During Transrectal Ultrasonography-Guided Prostate Biopsy: What Do We Know? (PDF)
During the last decade the development of prostate biopsy has continuously accelerated.

BJUI Mini Reviews 2005 November

Does Photodynamic Therapy Have The Necessary Attributes To Become A Future Treatment For Organ-Confined Prostate Cancer? (PDF)
Most would agree that there are too many treatment options for men with early prostate cancer.

BJUI Mini Reviews 2005 October

The Role of Bisphosphonates in the Treatment of Prostate Cancer (PDF)
Bisphosphonates are a routine treatment for patients with metastatic breast cancer and multiple myeloma, in which setting they have been shown to reduce the risk of fractures and the need for palliative radiotherapy [1].

BJUI Mini Reviews 2005 May

An Evidence-based Approach to Understanding the Pharmacological Class Effect in the Management of Prostatic Diseases (PDF)
Ever more alternative products are available for each drug type commonly used to treat prostatic diseases, i.e. α-blockers, 5α-reductase inhibitors, antiandrogens and LHRH agonists.

BJUI Mini Reviews 2005 April

Surgical Margin Status After Radical Retropubic Prostatectomy (PDF)
Since the early 1980s, improved knowledge of male pelvic anatomy, along with the refinement of surgical technique, have led to a dramatic change in the management of localized prostate cancer.

BJUI Mini Reviews 2005 February

Prostate Cancers in the Transition Zone: Part 1: Pathological Aspects (PDF)
There are several anatomical models of the prostate but the one currently used by pathologists and clinicians was established by McNeal et al.[1].

BJUI Mini Reviews 2005 February

Prostate Cancers in the Transition Zone: Part 2: Clinical Aspects (PDF)
Current knowledge about the anatomical architecture of the human prostate gland is largely determined by the studies of McNeal [1].

BJUI Mini Reviews 2005 February

Hormonal Therapy Options for Prostate-specific Antigen-only Recurrence of Prostate Cancer After Previous Local Therapy (PDF)
The ‘PSA era’, which now spans > 15 years (1988 to present), has dramatically altered the epidemiology of prostate cancer in the USA and many other industrialized countries.

BJUI Mini Reviews 2005 February

Neuroprotective Strategies in Radical Prostatectomy (PDF)
Prostate cancer is the most common malignancy among men in Western society. In the USA alone, 200 000 men were diagnosed with prostate cancer in 2003.

BJUI Mini Reviews 2005 January

Robotic Urological Surgery: A Perspective (PDF)
We appear to be heading towards a digital surgical future; high-tech minimally invasive surgery and more recently robotics are examples. Despite these surgical advances it is important to keep things in context.

BJUI Mini Reviews 2005 January

The Molecular Staging of Prostate Cancer (PDF)
The natural history of prostate cancer is notoriously variable and whilst some tumours remain indolent for many years, others result in rapid progression to metastasis and death.

BJUI Mini Reviews 2004 December

Three-Dimensional Imaging in Urology (PDF)
Bestowed with binocular vision, humans can appreciate the world around them in three dimensions.

BJUI Mini Reviews 2004 October

Androgen Receptor Polymorphisms And Risk of Biochemical Failure Among Prostatectomy Patients
Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, Pettaway CA, Shete S, Spitz MR, Logothetis CJ.
Prostate. 2004 Sep 1;60(4):343-51

2004-10-11

Development of Prostate Cancer Treatment: The Good News
The authors cover the subject thoroughly, and propose that there has been a real increase in prostate cancer survival since 1985.

2004-02-10

Prostate-specific Antigen Doubling Time Identifies Patients at Risk after Prior Treatment (Paraphrased)
An extensive review of present information on using this clinical tool to manage patients who relapse after definitive therapy for prostate cancer.

2004-02-04

Hormonal Therapy Options for Patients with PSA Failure After Primary Therapy of Cancer of Prostate (Paraphrased)
Every therapy used or usable is covered in this complete review.

2004-02-04

Robotic Surgery: Urologic Implications
If you don't believe that robots will impact urologic practice, read this article.

2004-02-19

Please log-in or register in order to submit comments.

Powered by AkoComment!